Guanoxan

DB13211ApprovedSmall molecule

Guanoxan is an antihypertensive agent similar in its mechanism of action to guanethidine; may cause liver damage. Guanoxan was approved in the UK but was withdrawn from the market due...

Formula / weight: C₁₀H₁₃N₃O₂ · 207.233 g/mol (avg)
Code names: BRN 1251616

Resolves to

Compound

UNII9V0MRL0R5YCAS2165-19-7ChEMBLCHEMBL76725ChEBI134871

Clinical / RWD

ATCC02CC03

Structure

InChIKeyHIUVKVDQFXDZHU-UHFFFAOYSA-NSMILESNC(=N)NCC1COC2=C(O1)C=CC=C2

What you can answer from here — as of August 30, 2026

633Drug interactionsStructured to mechanism, not free text

1ATC codeIncluding every combination product, plus 4 drug categories

Which companies are running trials of Guanoxan, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account